October is Breast Cancer Awareness month and in observance, consumer market research firm Scarborough has analyzed women and healthcare, or, “Health-Conscious Women.” Defined by Scarborough as American adult women who agree that they go to the doctor regularly for checkups, generally feel they eat right and follow a regular exercise routine, Health-Conscious Women make up [ Read More ]
Many women are choosing to self-treat their own breast cancer, according to a survey conducted by TMD Limited, a medical tourism company. When faced with the possibility of losing a breast or being side-lined by chemotherapy, some women are going the natural route and treating themselves. The internet offers hundreds of products and websites that [ Read More ]
Identifying the cellular origins of breast cancer might lead to earlier diagnosis and more efficient management of the disease. New research led by Charlotte Kuperwasser of Tufts University School of Medicine (TUSM) has determined that common forms of breast cancer originate from breast cells known as luminal epithelial cells while rarer forms of breast cancer, [ Read More ]
RNL Natural Co. introduced on June 22, 2011 a new method of detecting breast cancer as early as at ‘stage 0′ through breath VOCs (volatile organic compounds, a predictor of breast cancer). Researchers at RNL conducted a study of 35 women diagnosed with breast cancer and 35 healthy women not suffering from the disease. These [ Read More ]
Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the latest issue of the peer-reviewed journal, Integrative Cancer Therapies. Lead investigator Dr. Daniel Sliva says, “The formula we studied inhibits growth of highly metastatic human breast cancer cells, [ Read More ]
Halaven(TM) Black Triangle Drug (eribulin), a novel treatment for patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease is launched today in the United Kingdom. Prior therapy should have included two common types of chemotherapy, an anthracycline and a taxane, unless patients were not [ Read More ]